allogeneic clonal bone marrow-derived mesenchymal stromal cells (Royan Institute)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameallogeneic clonal bone marrow-derived mesenchymal stromal cells (Royan Institute)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLow Back Pain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIran
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesRoyan Institute
China Registration ClassN/A

Develop Information

Active CompaniesRoyan Institute
Inactive CompaniesN/A
Active IndicationsLow Back Pain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A